Longitudinal MRI study of multiple system atrophy - when do the findings appear, and what is the course?

Yoshihiko Horimoto1, Ikuko Aiba, Takeshi Yasuda

  • 1Second Department of Internal Medicine, Medical School, Nagoya City University, Mizuho, Japan.

Journal of Neurology
|July 26, 2002
PubMed

Insights

Magnetic resonance imaging (MRI) reveals distinct timelines for pontine "cross sign" and putaminal "slit" in multiple system atrophy (MSA) subtypes. These MRI findings aid in diagnosing MSA and differentiating subtypes based on lesion progression rates.

Area of Science:

  • Neurology
  • Radiology
  • Medical Imaging

Background:

  • Multiple System Atrophy (MSA) diagnosis relies on identifying characteristic MRI features.
  • Understanding the temporal evolution of these MRI findings is crucial for accurate diagnosis and subtyping.

Purpose of the Study:

  • To determine the exact timing of key MRI features (pontine "cross sign" and putaminal "slit") in MSA.
  • To investigate the progression of MRI findings and their correlation with clinical subtypes (MSA-C, MSA-A, MSA-P).

Main Methods:

  • Longitudinal cranial MRI analysis of 42 patients with MSA.
  • Staging of pontine "cross sign" (6 stages) and putaminal "slit" (4 stages).
  • Classification of patients into MSA-C, MSA-A, and MSA-P subtypes.

Main Results:

  • Pontine "cross sign" completion occurred earlier in MSA-C (before 5 years), later in MSA-P, and much later in MSA-A.
  • "Putaminal slit" showed earlier bilateral changes in MSA-P (before 3 years) compared to MSA-C (4 years for unilateral) and MSA-A.
  • MRI findings correlated with clinical subtypes: MSA-C showed earlier "cross sign" than "putaminal slit"; MSA-P showed earlier bilateral "putaminal slit" than "cross sign".

Conclusions:

  • MRI findings exhibit distinct temporal patterns that correlate with MSA clinical subtypes.
  • These observations support the use of MRI for diagnosing MSA and differentiating between MSA-C, MSA-A, and MSA-P based on lesion progression.